NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia.
Semin Oncol. 2011 Jun;38(3):380-5. doi: 10.1053/j.seminoncol.2011.03.007.
Most patients with incurable cancer want information about the impact cancer will have on their future, and many want specific estimates of the most likely, best case, and worst case scenarios for survival. With improved understanding of life expectancy, patients are better equipped to make appropriate treatment decisions and plans for the future. Although physicians acknowledge that patients with incurable cancer want prognostic information and benefit from this, most struggle to provide it and experience difficulty in making reliable estimates, communicating them, and tailoring the information to the individual patient. In this review we address some of the implications that arise from thinking and talking about life expectancy with people who have incurable cancer, particularly those considering first- or second-line chemotherapy.
大多数患有绝症的患者希望了解癌症对其未来的影响，许多患者希望获得对生存最可能、最佳和最差情况的具体估计。随着对预期寿命的理解的提高，患者能够更好地做出适当的治疗决策和未来规划。尽管医生承认患有绝症的患者希望获得预后信息并从中受益，但大多数医生在提供该信息方面仍面临困难，难以做出可靠的估计，沟通信息，并将信息定制为个体化患者。在这篇综述中，我们探讨了与患有绝症的人（尤其是考虑一线或二线化疗的患者）讨论预期寿命时所产生的一些影响。
